A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases.
Body JJ, Greipp P, Coleman RE, Facon T, Geurs F, Fermand JP, Harousseau JL, Lipton A, Mariette X, Williams CD, Nakanishi A, Holloway D, Martin SW, Dunstan CR, Bekker PJ.
Body JJ, et al. Among authors: coleman re.
Cancer. 2003 Feb 1;97(3 Suppl):887-92. doi: 10.1002/cncr.11138.
Cancer. 2003.
PMID: 12548591
Free article.
Clinical Trial.